| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| Other Sizes |
|
| Targets |
cdk2-cyclin A (IC50 = 0.41 μM);CDK1-Cyclin B (IC50 = 6.6 μM); CDK4-Cyclin D (IC50 = 5.5 μM); cdk5-p25 (IC50 = 15 μM); cdk7-cyclin H (IC50 = 3.9 μM); Aurora A (IC50 = 67 nM); Aurora B (IC50 = 35 nM)
|
|---|---|
| ln Vitro |
NU6140 has IC50 values of 6.6, 5.5, 15, and 3.9 μM for CDK1-cyclin B, CDK4-cyclin D, CDK5-p25, and CDK7-cyclin H, respectively, indicating that it is less active than other cyclins.
NU6140 causes an increase in the sub-G1 apoptotic cell population and increases the catalytic activity of capases-9 and-3[1]. |
| References |
|
| Molecular Formula |
C23H30N6O2
|
|---|---|
| Molecular Weight |
422.52
|
| Exact Mass |
422.24302
|
| Elemental Analysis |
C, 65.38; H, 7.16; N, 19.89; O, 7.57
|
| CAS # |
444723-13-1
|
| Related CAS # |
444723-13-1
|
| Appearance |
Solid powder
|
| SMILES |
CCN(CC)C(=O)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)OCC4CCCCC4)NC=N3
|
| InChi Key |
XHEQSRJCJTWWAH-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C23H30N6O2/c1-3-29(4-2)22(30)17-10-12-18(13-11-17)26-23-27-20-19(24-15-25-20)21(28-23)31-14-16-8-6-5-7-9-16/h10-13,15-16H,3-9,14H2,1-2H3,(H2,24,25,26,27,28)
|
| Chemical Name |
4-[[6-(cyclohexylmethoxy)-7H-purin-2-yl]amino]-N,N-diethylbenzamide
|
| Synonyms |
NU 6140; NU-6140; NU6140
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: ~250 mg/mL (591.7 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (4.92 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (4.92 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.3668 mL | 11.8338 mL | 23.6675 mL | |
| 5 mM | 0.4734 mL | 2.3668 mL | 4.7335 mL | |
| 10 mM | 0.2367 mL | 1.1834 mL | 2.3668 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
|
|
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
